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Abstract
Objectives: Despite growing research interest in spirituality and health, and recommendations on the
importance of spiritual care in advanced cancer and palliative care, relationships between spiritual
belief and psychological health near death remain unclear. We investigated (i) relationships between
strength of spiritual beliefs and anxiety and depression, intake of psychotropic/analgesic medications
and survival in patients with advanced disease; and (ii) whether the strength of spiritual belief changes
as death approaches.
Methods: We conducted a prospective cohort study of 170 patients receiving palliative care at home,
97% of whom had a diagnosis of advanced cancer. Data on strength of spiritual beliefs (Beliefs and
Values Scale [BVS]), anxiety and depression (Hospital Anxiety and Depression Scale [HADS]),
psychotropic/analgesic medications, daily functioning, global health and social support were collected
at recruitment then 3 and 10 weeks later. Mortality data were collected up to 34 months after the ﬁrst
patient was recruited.
Results: Regression analysis showed a slight increase in strength of spiritual belief over time
approaching statistical signiﬁcance (+0.16 BVS points per week, 95% CI [0.01, 0.33], p= 0.073).
Belief was unrelated to anxiety and depression (0.15 points decrease in HADS for 10 points increased
in BVS (95% CI [0.57, 0.27], p= 0.49) or consumption of psychotropic medication). There was a non-
signiﬁcant trend for decreasing analgesic prescription with increasing belief. Mortality was higher
over 6 months in participants with lower belief at recruitment.
Conclusion: Results suggest that although religious and spiritual beliefs might increase marginally as
death approaches, they do not affect levels of anxiety or depression in patients with advanced cancer.
© 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.
Introduction
Oncologists’ interest in palliative care has been stimulated
by recent evidence of its positive effect on outcomes in
some patient groups [1–3]. Recent guidelines on quality
standards in palliative care from the UK National Institute
for Clinical Excellence stress the importance of providing
spiritual care according to individual need and preference
[4]. It may be viewed as a component of active rehabilitation
in advanced disease [5]. Religious and spiritual beliefs
may strengthen a person’s resilience to depression or
anxiety, at least in part by providing meaning and purpose
in their experiences.
However, evidence for the impact of spiritual beliefs on
psychological and physical health is mixed. Whereas
some studies report that beliefs correlate with less depres-
sion and anxiety [6–8], greater quality of life [9], less
perceived pain [10] and increased survival [11], others
suggest the reverse or no direct effects [12–14]. Much
work has focused on chronic illness, increasingly relevant
in cancer, and stronger beliefs may augment illness adjust-
ment [15–17]. Our recent Cochrane review of interventions
with a deﬁnite spiritual or transcendent component found
some evidence of effectiveness in improving wellbeing
[18]. Fewer studies have measured change in belief, espe-
cially in advanced illness [7]. A lack of consistent ﬁndings
may reﬂect difﬁculties conceptualising and measuring
spirituality [19–23], the limitations of cross-sectional
designs and inadequate adjustment for confounding
inﬂuences [21]. Spiritual measures may have doubtful
psychometric properties or commingle spiritual beliefs
with psychological variables [24].
Depression and anxiety are common in people treated for
advanced, progressive disease who face the end of their
lives [25,26]. We report a prospective study of the impact
of the strength of spiritual beliefs on anxiety and depression
in cancer patients receiving specialist palliative care in the
UK by using a measure of spirituality which does not con-
ﬂate spirituality with psychological variables: the Beliefs
and Values Scale (BVS) [27]. The BVS is based on detailed
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qualitative work and centres on a multidimensional and
inclusive conceptualisation of spirituality, which reﬂects
the deﬁnition of spirituality agreed upon by the European
Association of Palliative Care taskforce for Spirituality in
Palliative Care:
Spirituality is the dynamic dimension of human life that
relates to the way persons (individual and community)
experience, express and/or seek meaning, purpose and
transcendence, and the way they connect to the moment,
to self, to others, to nature, to the signiﬁcant and/or the
sacred [28].
We acknowledge the importance of making clear how
spirituality is or is not deﬁned in medical research and
health service provision and further point readers towards
the more detailed conceptualisation of spirituality
published by King and Koenig [29].
In this study, we aimed to investigate the hypotheses that
(i) spiritual beliefs become stronger towards the end of life,
and that stronger spiritual beliefs are associated with (ii) less
anxiety and depression, (iii) lower intake of psychotropic
and analgesic medications, and (iv) increased survival in
patients with advanced illness.
Method
Design
A prospective cohort study was conducted over 10 weeks.
Sample and recruitment
Patients older than 18 years, receiving specialist palliative
care at home and able to give written informed consent were
eligible for inclusion in the study. Patients unable to under-
stand English or whose death was considered imminent
were excluded. Patients were recruited through nine special-
ist palliative care teams across London over 26 months
(August 2007–September 2009). Eligible patients were
identiﬁed by palliative care teams who screened their
clinical case loads. Those eligible were contacted ﬁrst by
the palliative care teams, and the names of those agreeing
to being contacted were forwarded to the research team. Re-
searchers then contacted those interested to explain the study
in more detail and arrange a baseline visit. Patients were seen
by a researcher either at home or in a hospice, and informed
consent was taken at ﬁrst interview. In order to address the
difﬁculty of conducting empirical research in palliative care
settings, regular research brieﬁng and education sessions
were held with local palliative care teams to emphasise the
value of research and address individual concerns.
Ethics
A favourable opinion was received from the Essex 1
Research Ethics Committee (8 May 2007, ref 07/Q0301/3).
Procedure
Patients were assessed at baseline and after 3 and 10 weeks
by one of two researchers, both graduates in psychology
and experienced in conducting interviews with vulnerable
groups on sensitive research topics (F.O./H. L.). Researchers
met regularly with clinical members of the research team for
debrieﬁng and supervision. Patients were given the opportu-
nity to complete measures by themselves or with researchers
who read out questions verbatim and recorded responses. At
each time-point, data were collected on our main variables,
namely spiritual beliefs and psychological status, as well as
other factors including daily function, somatic symptoms,
physical health status and information on all prescribed
medication, including analgesic and psychotropic drugs.
At baseline, patients were also asked to complete question-
naires on basic demographic data and social support. In
order to test whether a response shift occurred during
follow-up, a random half of participants were asked to rate
the BVS again according to how they felt at baseline (the
so-called then-test).
Measures
Demographic questionnaire
Information on age, sex, religious afﬁliation and prac-
tice, education, socioeconomic status, ethnicity, marital
status, diagnosis and duration of illness was collected
at recruitment.
Medical Outcomes Study social support scale
Patients’ level of social support was measured at recruit-
ment using the Medical Outcomes Study social support
scale [30].
Beliefs and Values Scale
The BVS [27] is a multidimensional, validated and reliable
measure of spiritual belief, irrespective of religious belief or
practice. It comprises 20 statements, which were developed
from detailed qualitative research with a diverse sample of
ill and healthy people. Each statement in the scale has a
response in a 5-point Likert format, all of which sum to a
total score for strength of belief from 0 to 80. A higher score
indicates stronger belief. The scale was speciﬁcally devel-
oped to facilitate a distinction between religious and spiri-
tual belief. Whereas some items refer to more traditional
religious concepts, for example, ‘I believe there is a God’,
others refer to broadly conceived spiritual concepts such
as ‘I feel most at one with the world when surrounded by na-
ture’. In order not to conﬂate belief and health or wellbeing,
the scale does not contain items on coping or wellbeing.
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a
short questionnaire to assess anxiety and depression that
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is widely used in healthcare research and practice [31–35].
It comprises 14 items, giving a total score between 0 (no
anxiety or depression) and 42. It has well-established psy-
chometric properties and is quick and easy to complete by
people with poor health.
National Comprehensive Cancer Network
distress thermometer
The National Comprehensive Cancer Network distress
thermometer is a simple measure of overall psychological
distress ranging from 0 (no distress) to 10 (extreme distress),
developed in the USA and validated for use in a UK popu-
lation [36].
EQ-5D
The EQ-5D is a well-standardised, sensitive measure of
daily functioning [37]. It is composed of ﬁve questions that
combine a score of utility. In addition, participants are also
asked to rate their overall health state on a 100-point visual
analogue scale.
Karnofsky Performance Status scale
The Karnofsky Performance Status scale [38], a 10-point
scale completed by the researcher, was used to measure
likely disease progression and global performance status.
Researchers were given guidance on using the measure
by the clinical leads on the study (L. J./A. T.).
Prescribed medication
Patients were asked to report use of analgesic and psycho-
tropic medications at each assessment. Patients who were
unsure which medications they were taking were asked to
produce medication bottles or prescription lists, and details
were recorded.
Survival
Mortality data on all patients were collected for 34 months
after the ﬁrst patient was recruited.
Statistical methods
A statistical analysis plan was developed before the data
were explored. We used descriptive statistics to report on
the cohort at each assessment point. Participant character-
istics were compared with level of belief by dichotomizing
at the median BVS score. All subsequent analyses were
based on imputed data. By taking into account measured
predictors of missingness, multiple imputation predicts
missing data to reduce the risk of bias, whilst preserving
the uncertainty surrounding the imputed values. Multiple
data imputations were conducted for each speciﬁc analysis
using variables predicting missing data, as well as those
included in each analysis model and any strongly corre-
lated with them. We conducted multiple imputations by
chained equation using the ice package in STATA [39] to
generate 30 sets of imputed data. We obtained combined
estimates using Rubin’s rules [40].
Change of belief over time, the relation between BVS
and HADS, and the relation between BVS and reported
consumption of medication were analysed using general-
ised estimating equation (GEE), which relaxes the assump-
tions of independent observations in the analysis of repeated
measurements [41]. GEE were ﬁtted using exchangeable
correlation matrices and robust standard errors. We also
explored baseline predictors of change in belief using linear
regressions adjusted for baseline belief.
In order to investigate a possible change in internal stan-
dards over time when participants completed the BVS
(response shift), we compared the BVS score at recruitment
and its retrospective scoring at week 10 (then-test) [42]. The
degree of response shift is estimated from the mean differ-
ence between the baseline and then-test scores.
For the survival analysis, BVS was divided into terciles
(decided a priori to have informative group sizes) and
compared using the logrank test. As the impact of a low
belief seemed to differ before and after 6 months, we
conducted a further analysis on the basis of the ﬁndings,
not on an a priori hypothesis. In this post hoc analysis,
we ﬁtted a Cox proportional hazard model with two sepa-
rate coefﬁcients.
The sensitivity of our results to imputation was examined
by repeating the analyses in the observed data. All analyses
were performed using STATA release 11 [43]. All tests were
two sided and considered signiﬁcant at the 5% level.
Power and sample size
In developing the protocol, we assumed that the main anal-
ysis would be a multivariable regression in which we would
include up to 10 predictor variables. We used a statistical
rule of thumb that 15–20 participants would be required
for each variable adjusted for in themodel, whichmeant that
we needed to obtain data on between 150 and 200 patients.
Results
Our descriptive and survival analyses are based on observed
data, whereas GEE models are derived from multiply
imputed data.
Recruitment and attrition
Palliative care professionals approached 494 eligible
patients, of whom 302 were referred to the research team.
Of these, 132 (44%) did not participate (see Figure 1 for
reasons). Therefore, 170 (34%) of the 494 patients
approached by palliative care professionals were seen at
baseline. Of these, 137 (81%) completed the 3-week
assessment and 113 (67%) the 10-week assessment
(Figure 1). Participants dropping out were older (mean
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age 69 years vs. 64, p=0.03), had poorer health at baseline
(mean Karnofsky score 66 vs. 72, p= 0.007; mean EQ-5D
visual analogue score 48 vs. 59, p< 0.001) and were more
likely to have been prescribed steroids (31% vs. 11%,
p=0.001).
Population characteristics at recruitment
The majority of participants were women (62%) and of
white ethnicity (85%) (Table 1). Mean age was 66 years
(SD 13.8, range 22 to 96), and whereas 60% identiﬁed
themselves as Christian, 28% did not observe a religion.
Lung and breast cancer were the most frequent diagnoses.
Reﬂecting clinical caseload, four patients had an advanced
disease other than cancer. Thirty-nine per cent of partici-
pants reported use of psychotropic medication, 45% analge-
sics and 19% steroids.
At recruitment, the median BVS score was 54 and the
median HADS score was 10 (Table 2). Twenty-seven
per cent of participants scored above the threshold of
8 on the HADS depression subscale, indicating moderate
or severe depressive symptoms. Thirty-four per cent
scored above 8 on the HADS anxiety subscale, indicating
moderate or severe anxiety. After dividing participants
into two groups according to the median BVS score, level
of belief was signiﬁcantly related to gender, ethnicity and
religious denomination (Table 1).
Change in belief
The GEE model using imputed data showed a slight but
non-signiﬁcant increase in BVS score of 0.16 points per
week on average (95% CI [0.01, 0.33], p= 0.073). At
week 10, 57 patients completed the retrospective assess-
ment of their belief at recruitment. The mean response
shift over 10 weeks was 0.15 (1.73, 2.02, p= 0.88),
suggesting stable personal internal standards when rating
beliefs. No baseline variable was predictive of change in
belief over 10 weeks (p-values range 0.22 to 0.94), with
the exception of distress, which was associated with a
greater increase in belief. For each additional point on
the distress thermometer (indicating greater distress) at
baseline, the change in BVS score over 10 weeks was
greater by 0.67 points (stronger belief) (95% CI [0.10,
1.23], p = 0.022).
Belief and psychological status
The relation between BVS and HADS was not signiﬁcant
(for each additional 10 points on the BVS, the HADS
score varied by 0.16 (95% CI [0.60, 0.29], p= 0.49)),
indicating no relationship between belief and psychological
status over 10 weeks. Adjustment for age, sex, duration of
illness, social support, physical functioning and use of
steroids, psychotropic medication and analgesics made
no difference to this result (Table 3).
In an exploratory analysis, the HADS was also not asso-
ciated with either of the two principal factors of the BVS
(religious and non-religious spirituality). We also explored
the relationship between individual items of the BVS and
the HADS; results are reported in Supplementary Table 1.
Although none were statistically signiﬁcant, the strongest
associations with less psychological distress were in agree-
ment with seven traditional statements on religious beliefs
(items 3, 5, 7, 13, 14, 17 and 20—Supplementary Table 1).
Belief and drug prescription
No relationship was found between BVS scores and psy-
chotropic medication, either unadjusted (odds ratio (OR)
for each 10 points increase in BVS=0.95, 95% CI [0.79,
1.12], p=0.52) or after adjustment for gender, age, duration
of illness, social support and Karnofsky score (OR=0.94,
95% CI [0.78, 1.13], p=0.49). There was a non-
signiﬁcant trend for lower analgesic consumption in those
with higher BVS scores (OR=0.91, 95% CI [0.80, 1.03],
p= 0.13, adjusted OR=0.90 95% CI [0.80, 1.03], p=0.13).
Belief and survival
Long-term survival was very similar for the three belief
groups (BVS score categorised into terciles) (logrank test,
p= 0.81) (Figure 2).
However, the effect of low belief (BVS score< 40—the
lower tercile) on mortality seemed to differ before and
after 6 months. We therefore ﬁtted a Cox proportional
hazards model, allowing for the effect of low belief to
change over time. The unadjusted HR in the ﬁrst 6 months
was 2.19 (95% CI [1.30, 3.70], p= 0.003), indicating that
those with a BVS score below 40 had twice the mortality
as those with a BVS score over 40. The effect remained
after adjustment for age, gender, type of diagnosis (upper
Enrolled
(N=170)
Attrition at week 10 (N=31):
- Died (n=11)
- Too ill to participate (n=11)
- Withdrew (n=4)
- Unable to contact (n=5)
Eligible patients 
referred by 
palliative care 
teams (N=302)
Did not participate (N=132, 44%):
- Died before consent taken (n=32)
- Refused (n=56)
- Too ill to participate (n=35)
- Unable to contact (n=9)
Attrition at week 3 (N=26):
- Died (n=4)
- Too ill to participate (n=16)
- Withdrew (n=6)
Seven participants missed week 
3 but were seen at week 10.
Week 3
(N=137, 81%)
Week 10
(N=113, 67%)
Eligible patients 
approached by 
palliative care 
teams (N=494)
Not referred to research 
team (N=192, 39%):
- Details on reasons for 
refusal are not 
available
Figure 1. Recruitment and attrition
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gastrointestinal or lung cancer vs. other), time from diag-
nosis and Karnofsky score (HR=2.45, 95% CI [1.42,
4.22], p=0.001). After 6 months, the mortality rate was
lower for patients with low belief, but the difference was
not signiﬁcant (unadjusted HR=0.57, 95% CI [0.27,
1.20], p= 0.136, adjusted HR=0.60, 95% CI [0.28, 1.28],
p= 0.187).
Sensitivity to data imputation
As described earlier, 33 and 57 participants did not attend
week 3 and week 10 visits, respectively, giving an overall
Table 1. Participants characteristics overall and by level of belief
Characteristic Overall (n=170)a BVS< 54 (n= 85) BVS≥ 54 (n=84) p-valueb
Sex
Female 106 (62) 46 (54) 60 (71) 0.026
Age
Mean (SD) (years) 66.2 (13.8) 65.6 (15.2) 66.6 (12.3) 0.631
Marital status
Married/living with partner 71 (42) 35 (41) 35 (42) 1.00
Ethnicity
White 145 (85) 82 (96) 62 (74) <0.001
Black 16 (10) 2 (2) 14 (17)
Other 9 (5) 1 (1) 8 (10)
Education (n=169)c
No qualiﬁcation 63 (37) 27 (32) 35 (42) 0.080
GCSE/A-level/higher education 47 (28) 26 (31) 21 (25)
Degree 42 (25) 26 (31) 16 (19)
Other 17 (10) 5 (6) 12 (14)
Employment status (n=169)
Employed 16 (9) 12 (14) 4 (5) 0.207
Unemployed 22 (13) 11 (13) 11 (13)
Retired 115 (68) 53 (63) 61 (73)
On sick leave 16 (9) 8 (10) 8 (10)
Religion (n=169)
Does not observe a religion 47 (28) 45 (54) 2 (2) <0.001
Christianity—Protestant 52 (31) 16 (19) 35 (42)
Christianity—Roman Catholic 35 (21) 9 (11) 26 (31)
Christianity—other 14 (8) 4 (5) 10 (12)
Judaism 10 (6) 7 (8) 3 (4)
Other 11 (7) 3 (4) 8 (10)
Tumour site (n=168)
Lung 35 (21) 21 (25) 14 (17) 0.609
Upper gastrointestinal 29 (17) 10 (12) 19 (23)
Breast 24 (14) 11 (13) 13 (16)
Genito-urinary 22 (13) 12 (14) 9 (11)
Colorectal 20 (12) 12 (14) 8 (10)
Gynaecological 12 (7) 5 (6) 7 (8)
Haematological 10 (6) 4 (5) 6 (7)
Central nervous system 6 (4) 3 (4) 3 (4)
Other cancer 6 (4) 3 (4) 3 (4)
Non cancer 4 (2) 3 (4) 1 (1)
Time from diagnosis (n=168)
Median (IQR) (months) 17 (6–42) 18 (7–41) 15 (6–42) 0.631
Frequency (%), mean (SD) or median (IQR). BVS, Beliefs and Values Scale; GCSE, General Certiﬁcate of Secondary Education; IQR, interquartile range.
aIncluding one participant with missing total BVS score.
bp-values for differences by BVS group from chi-square, t-test (age) or Mann–Whitney (time from diagnosis) tests.
cn reported when different from 170.
Table 2. Questionnaires score at each follow-up (median scores
and interquartile ranges)
Questionnaire
Recruitment
(n=170)
Week 3
(n=137)
Week 10
(n=113)
BVS 54 (36–68) 56 (40–68) 58 (42–71)
HADS 10 (7–15) 11 (7–15.5) 11.5 (6–15.5)
Distress 3 (1–5) 4 (1–6) 4 (1–6)
EQ-5 VAS 50 (40–70) 60 (40–70) 50 (40–70)
EQ-5 score 0.66 (0.26–0.76) 0.69 (0.27–0.80) 0.62 (0.19–0.81)
Karnofsky 70 (60–80) 70 (60–80) 70 (60–80)
BVS, Beliefs and Values Scale; HADS, Hospital Anxiety and Depression Scale; VAS,
visual analogue scale.
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proportion of missing data of 18%. There was little differ-
ence in our ﬁndings in the complete case analysis. For
example, the unadjusted coefﬁcient for the relationship
between a 10 points’ change on BVS and HADS was
0.18 (p= 0.394). However, some results close to signif-
icance on imputed data were signiﬁcant on complete case
data; this was the case for change in belief (coefﬁcient
0.15, 95% CI [0.01, 0.30], p= 0.036) and for the relation
between belief and analgesic use (adjusted OR 0.90,
95% CI [0.81, 0.99], p= 0.031).
Discussion
Main ﬁndings
Over 97% of participants had advanced cancer, and the
strength of their spiritual beliefs increased slightly but
non-signiﬁcantly over 10 weeks. We found no relation-
ship between strength of belief and anxiety or depression
either at recruitment or during follow-up. Nor was belief
associated with use of psychotropic medication. However,
there was a trend for decreasing analgesic prescription
with increasing belief, but again this was non-signiﬁcant.
In a post hoc analysis, we observed higher mortality over
6 months in participants with lower belief scores.
Relevance of our ﬁndings
Our ﬁndings challenge the suggestion that stronger spiritual
beliefs are associated with less anxiety and depression near
the end of life. The stress experienced as death approaches
may be so overwhelming that it overwhelms any psycho-
logical advantage available to well people with spiritual
beliefs. However, this explanation is not supported by data
from a national psychiatric morbidity study in the UK [44]
or a recent prospective study in a large European popula-
tion, both of which suggest that spiritual belief is not associ-
ated with markers of psychological wellbeing such as
anxiety and depression in well people either [45].
Many studies reporting positive associations have used
instruments to measure religious and spiritual belief that
contain questions assessing positive character traits or
good mental health, for example, optimism, peacefulness,
harmony and general wellbeing [24]. Thus, religion and
spirituality are conﬂated with psychological outcomes,
and it is not surprising that research using such measures
reports positive associations. The BVS avoids this pitfall
by limiting itself to the nature and strength of belief. It
also has relevance to people who are not involved in
organised religion.
Our sample population was made up almost entirely of
people with cancer. Although for some the illness is short,
others may endure repeated relapse and recurrence, and
adjustment may vary according to experience and type
of cancer [46–48].
We observed a small but non-signiﬁcant increase in
strength of spiritual belief over 10 weeks. A response-shift
analysis conﬁrmed that this was not caused by a change of
internal standards (recalibration) on completing the BVS.
Although this indicates that patients may increase their
belief as death approaches, we acknowledge that our
research may have increased patients’ propensity to reﬂect
about spiritual matters and thus altered the natural course
of their faith or beliefs.
We hypothesised that palliative care patients with stron-
ger spiritual beliefs might experience less psychological
distress and have less need for psychotropic or analgesic
medication. Although our ﬁnding that belief and wellbeing
were not related challenged this assumption, we observed a
slightly lower prescription of analgesics in patients with
stronger beliefs. However, this was non-signiﬁcant.
We also observed higher mortality in the 6 months
following recruitment for patients with lower beliefs;
however, this difference was not sustained. Despite the
signiﬁcance of this post hoc ﬁnding, there is no clear
Table 3. Adjusted relationship between BVS and HADS
Coefﬁcient 95% CI Signiﬁcance
Factor of interest
BVS score (10 units) 0.15 [0.57, 0.27] 0.49
Adjustment covariates
Time (weeks) 0.02 [0.10, 0.15] 0.71
Gender (male) 0.89 [1.08, 2.85] 0.38
Age (years) 0.05 [0.11, 0.01] 0.13
Duration of illness (log (days)) 0.57 [1.34, 0.20] 0.14
MOS Social Support Survey 0.85 [1.89, 0.19] 0.11
Steroid use 0.92 [3.23, 1.38] 0.43
Psychotropic use 0.93 [1.23, 3.09] 0.40
Analgesic use 0.41 [1.49, 2.32] 0.67
Karnofsky Performance
Status score
0.11 [0.18, 0.05] 0.001
From generalised estimating equation model with HADS as dependent variable, on
imputed data (n=170 3). BVS, Beliefs and Values Scale; HADS, Hospital Anxiety
and Depression Scale; MOS, Medical Outcomes Study.
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Figure 2. Kaplan Meir survival estimates from time of recruitment
to death, by level of belief
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explanation for the change of effect at 6 months, and
further investigation is needed. In a systematic review of
observational cohort studies, Chida et al. [11] reported
that religiosity/spirituality was not associated with sur-
vival in diseased populations (combined HR= 0.98, 95%
CI [0.94, 1.01], p= 0.19), whereas it was associated in
healthy populations (combined HR for mortality = 0.82,
95% CI [0.76–0.87], p< 0.001). In accounting for this
discrepancy, the authors suggested that once diseases are
established, identiﬁed and under treatment, religiosity/
spirituality may not affect outcome.
Implications of our ﬁndings
Our ﬁnding that spiritual and religious beliefs are not asso-
ciated with psychological status as death approaches does
not negate the potential value of including a spiritual
element in palliative care. Spiritual care is about being open
to discussing difﬁcult existential issues that patients or their
families may raise. It may well be that spiritual or religious
beliefs and values impact on outcomes other than those we
examined here. Furthermore, religious practice is a dimen-
sion we did not examine. However, the suggestion that
stronger spiritual beliefs are linked to less anxiety and
depression [49] is not supported here.
Limitations
Our overall response of 34% may appear relatively low,
but it is similar to that reported in much palliative care
research, particularly prospective designs [50]. We do
not have sufﬁcient information to compare participants
with non-participants, and there are potential recruitment
biases, including staff ’protecting’ sicker patients and
self-selection through interest in the study topic. In partic-
ular, there may be an under-representation of patients with
weaker spiritual or religious beliefs. This possibility is
supported by our ﬁnding that mean BVS scores in this
study were higher than in the populations on which the
questionnaire was validated [27]. The study population
may not be representative of all palliative care patients,
and caution is required in generalising the ﬁndings. The
risk of bias by attrition, an important concern in longitudi-
nal studies in palliative care [51], was limited by the use
of multiple imputations. Our sample size offered accept-
able power to test our hypotheses; the use of repeated
measurement and multiple imputations of missing data
enhanced that power. Borderline signiﬁcant results must
be interpreted with caution, however, taking into account
the increased risk of chance ﬁndings on multiple analyses.
Performance status was assessed by non-clinicians, which
may have introduced inaccuracy in ranking. Finally, self-
report data on medications may be inaccurate.
Conclusion
Our results suggest that stronger spiritual beliefs do not
mitigate anxiety and depression in people with advanced
cancer, but we cannot judge if spirituality is irrelevant to
other aspects of wellbeing, or whether more complex
processes near death are occurring, which limit any possi-
ble measurable advantage.
Supporting information
Supporting information may be found in the online version
of this article.
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